Two drug distribution companies at one point controlled 60% of the prescription opioid market in the Baltimore area, sending ...

The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drugmaker Johnson & Johnson ...

Bloomberg News had reported last month that McKesson and rival drug distributors Cencora and Cardinal Health were vying to ...

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over ...

McKesson, a drug distributor and medical-products company, will own a 70% stake in the company. Back To Top ...

McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics. Drug distributor McKesson will pay about $2.49 ...

The acquisition would give Irving, Texas-based drug distributor McKesson 70% ownership of that organization, and Florida Cancer Specialists' physicians would keep a minority interest, according to ...

Drug distributor McKesson could pay about $3.5 billion for the holding and a deal may be announced in the coming weeks, the people said, asking not to be named because the matter is private.

McKesson plans to grow its oncology platform by investing nearly $2.5 billion into a community oncology clinic operator’s business and administrative services arm. Announced Monday, the deal ...

Irving-based McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics. Drug distributor McKesson will pay ...

Aug 26 (Reuters) - Drug distributor McKesson (MCK.N), opens new tab said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's ...